Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04917809
Title A Study of Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

urinary bladder cancer

Therapies

Erdafitinib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST